Legal & General Group PLC Arvinas, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 62,954 shares of ARVN stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,954
Previous 62,954 -0.0%
Holding current value
$1.2 Million
Previous $1.55 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$23.66 - $32.73 $46,066 - $63,725
-1,947 Reduced 3.0%
62,954 $1.55 Million
Q2 2024

Aug 14, 2024
BUY
$24.46 - $40.4 $176,429 - $291,405
7,213 Added 12.5%
64,901 $1.73 Million
Q1 2024

May 14, 2024
BUY
$36.38 - $52.31 $398,797 - $573,422
10,962 Added 23.46%
57,688 $2.38 Million
Q4 2023

Feb 15, 2024
SELL
$14.19 - $42.33 $3,135 - $9,354
-221 Reduced 0.47%
46,726 $1.92 Million
Q3 2023

Nov 14, 2023
BUY
$19.64 - $28.21 $19,679 - $28,266
1,002 Added 2.18%
46,947 $922,000
Q2 2023

Aug 14, 2023
SELL
$21.73 - $31.43 $16,927 - $24,483
-779 Reduced 1.67%
45,945 $1.14 Million
Q1 2023

May 15, 2023
BUY
$26.15 - $37.26 $144,112 - $205,339
5,511 Added 13.37%
46,724 $1.28 Million
Q4 2022

Feb 14, 2023
SELL
$32.47 - $57.24 $15,585 - $27,475
-480 Reduced 1.15%
41,213 $1.41 Million
Q3 2022

Nov 14, 2022
BUY
$41.87 - $57.99 $70,844 - $98,119
1,692 Added 4.23%
41,693 $1.86 Million
Q2 2022

Aug 22, 2022
BUY
$36.01 - $74.24 $77,133 - $159,022
2,142 Added 5.66%
40,001 $1.68 Million
Q1 2022

May 16, 2022
BUY
$60.27 - $81.57 $54,122 - $73,249
898 Added 2.43%
37,859 $2.55 Million
Q4 2021

Feb 14, 2022
BUY
$65.85 - $96.21 $173,119 - $252,936
2,629 Added 7.66%
36,961 $3.04 Million
Q3 2021

Nov 15, 2021
BUY
$73.2 - $107.87 $532,749 - $785,077
7,278 Added 26.9%
34,332 $2.82 Million
Q2 2021

Aug 12, 2021
BUY
$60.45 - $84.26 $260,660 - $363,329
4,312 Added 18.96%
27,054 $2.08 Million
Q1 2021

May 17, 2021
BUY
$58.19 - $91.37 $1.01 Million - $1.59 Million
17,413 Added 326.76%
22,742 $1.5 Million
Q4 2020

Feb 12, 2021
BUY
$20.19 - $84.93 $107,592 - $452,591
5,329 New
5,329 $453,000

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email